Libyan Journal of Medicine
pISSN 1993-2820    eISSN 1819-6357
Current issue
Archival Issues
Search
Reviewers
 » 
Journal Abstract
 
Is There NO Treatment for Severe Sepsis?
A S Bredan  1, A Cauwels  1
1 - Department for Molecular Biomedical Research, VIB, Ghent, Belgium
Libyan J Med 2008; 3(1):34-38
ICID: 873571
Article type: Review article
IC™ Value: 2.40
Abstract provided by Publisher
 
Sepsis is a systemic inflammatory response syndrome in the presence of suspected or proven infection, and it may progress to or encompass organ failure (severe sepsis) and hypotension (septic shock). Clinicians possess an arsenal of supportive measures to combat severe sepsis and septic shock, and some success, albeit controversial, has been achieved by using low doses of corticosteroids or recombinant human activated protein C. However, a truly effective mediator-directed specific treatment has not been developed yet. Treatment with low doses of corticosteroids or with recombinant human activated protein C remains controversial and its success very limited. Attempts to treat shock by blocking LPS, TNF or IL-1 were unsuccessful, as were attempts to use interferon-gamma or granulocyte colony stimulating factor. Inhibiting nitric oxide synthases held promise but met with considerable difficulties. Scavenging excess nitric oxide or targeting molecules downstream of inducible nitric oxide synthase, such as soluble guanylate cyclase or potassium channels, might offer other alternatives.

ICID 873571
 
FULL TEXT 54 KB


Related articles
  • in IndexCopernicus™
         Protein C [43 related records]
         corticosteroids [20 related records]
         Nitric Oxide [535 related records]
         NOS [9 related records]
         Sepsis [135 related records]


  •  
     » 
    Comments
     
      
    Comments: 0
    Published remarks are private opinions of the users.
    Editorial office of the service do not take responsibility for them.

    Copyright © Libyan Journal of Medicine  2019
    Page created by Index Copernicus Ltd. All Rights reserved.